‘‘We are planning to deliver products with better efficiency for APAC customers''

Francis Van Parys, Vice President Commercial, Asia Pacific, Cytiva, South Korea

- Dr Manbeena Chawla

Cytiva, formerly GE Healthcare Life Sciences, has recently announced an investment of $500 million for expansion of its manufacturing capacity and hiring nearly 1000 personnel in Austria, China, Singapore, Sweden, and the United States. In addition, the company’s single-use capacity in the APAC region will triple through a partnership with healthcare technology supplier in China, Wego, which is already producing consumables for Cytiva’s customers in the region. BioSpectrum Asia took this opportunity to speak with Francis Van Parys, Vice President Commercial, Asia Pacific, Cytiva, South Korea, to find out what more is in store at Cytiva.

Edited excerpts;

What are the current opportunities being explored by Cytiva within the APAC region?